LIC of India:企業の戦略・SWOT・財務分析

◆英語タイトル:LIC of India - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3633
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

LIC of India – Strategy, SWOT and Corporate Finance Report
Summary

LIC of India – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

LIC of India (LIC or ‘the company’) is primarily involved in providing life insurance related services. These comprise of individual assurance, general annuities, pensions, non-linked health, unit linked business, and group insurance businesses. Its product portfolio includes endowment assurance plans, money back plans, term assurance plans, pension plans, special plan, Aam Admi Bima Yojna, unit plans, special plans, health plan and group schemes. LIC operates through its zonal areas located in Mumbai, Delhi, Kolkata, Chennai, Hyderabad, Kanpur, Bhopal, and Patna. The company primarily operates in India. LIC is headquartered in Mumbai, Maharashtra, India.

Scope

- Detailed information on LIC of India required for business and competitor intelligence needs
- A study of the major internal and external factors affecting LIC of India in the form of a SWOT analysis
- An in-depth view of the business model of LIC of India including a breakdown and examination of key business segments
- Intelligence on LIC of India’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about LIC of India, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of LIC of India and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess LIC of India as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on LIC of India’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
LIC of India: Company Overview
LIC of India: Overview and Key Facts
LIC of India: Overview
LIC of India: Key Facts
LIC of India: Key Employees
LIC of India: Key Employee Biographies
LIC of India: Major Products and Services
LIC of India: Company History
LIC of India: Management Statement
LIC of India: Key Competitors
LIC of India: Company Analysis
LIC of India: Business Description
LIC of India: SWOT Analysis
LIC of India: SWOT Overview
LIC of India: Strengths
LIC of India: Weaknesses
LIC of India: Opportunities
LIC of India: Threats
LIC of India: Corporate Financial Deals Activity
LIC of India: Financial Deals Overview
LIC of India: Targets and Partners
LIC of India: Top Deals 2015 – 2019YTD*
LIC of India: Advisors
LIC of India: Top Financial Advisors
LIC of India: Mergers and Acquisitions
LIC of India: Corporate Venturing
LIC of India: Partnership
LIC of India: Divestments
LIC of India: Recent Developments
LIC of India: News and Events Summary
LIC of India: Business Expansion
LIC of India: Contracts
LIC of India: Corporate Governance
LIC of India: Corporate Social Responsibility
LIC of India: Financial Deals
LIC of India: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: LIC of India: Key Facts
Table 2: LIC of India: Key Employees
Table 3: LIC of India: Company History
Table 4: LIC of India: Key Competitors
Table 5: LIC of India: Deal Activity by Deal Type - Volume (TTM*)
Table 6: LIC of India: M&A Activity by Geography (TTM*)
Table 7: LIC of India: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: LIC of India: M&A Average Deal Size - Value (US$m)
Table 9: LIC of India: Targets and Partners
Table 10: LIC of India: Top Deals 2015 - 2019YTD*
Table 11: LIC of India: Financial Advisor Ranking by Value (US$m)
Table 12: LIC of India: M&A Volume and Value Trend (2015 - YTD*2019)
Table 13: LIC of India: M&A Activity by Geography (2015 - YTD*2019)
Table 14: LIC of India: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 15: LIC of India: Corporate Venturing by Geography (2015 - YTD*2019)
Table 16: LIC of India: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 17: LIC of India: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 18: LIC of India: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 19: LIC of India: Divestments by Geography (2015 - YTD*2019)
Table 20: LIC of India: News and Events Summary
Table 21: LIC of India: Business Expansion
Table 22: LIC of India: Contracts
Table 23: LIC of India: Corporate Governance
Table 24: LIC of India: Corporate Social Responsibility
Table 25: LIC of India: Financial Deals
Table 26: LIC of India: Strategy and Operations

★海外企業調査レポート[LIC of India:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genesis Energy Ltd (GNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Genesis Energy Ltd (Genesis) is an energy company. It generates electricity and supplies that on retail and wholesale basis. The company also supplies gas and LPG, and related services to end-users; and sells and purchases electricity derivatives. Genesis produces power using coal, gas, hydr …
  • Linklaters Llp:企業の戦略・SWOT・財務分析
    Linklaters Llp - Strategy, SWOT and Corporate Finance Report Summary Linklaters Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • C.H. Robinson Worldwide Inc (CHRW):企業の財務・戦略的SWOT分析
    C.H. Robinson Worldwide Inc (CHRW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Haplogen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Haplogen GmbH (Haplogen) is a biopharmaceutical company that improves human health by fighting against infectious diseases such as common cold, dengue fever, influenza and hepatitis C. The company utilizes its proprietary genetics technology platform to identify novel pathogen host factors a …
  • Naia Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Naia Ltd (Naia) is a funding and developing company that address regional and global medical needs. The company develops and manufactures therapeutics for metabolic and rare diseases. It provides global drug development through funding, clinical development, organizational structure and regu …
  • Amdocs Ltd (DOX):企業の財務・戦略的SWOT分析
    Amdocs Ltd (DOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SeaBird Exploration PLC (SBX):石油・ガス:M&Aディール及び事業提携情報
    Summary SeaBird Exploration PLC (SeaBird) is an oil and gas company that offers marine seismic data services. The company’s services include 2D seismic acquisition, 3D and 3D shallow water acquisition and source vessel. Its source vessels offers services such as conventional undershoots, 4d repeat s …
  • iRhythm Technologies Inc (IRTC):医療機器:M&Aディール及び事業提携情報
    Summary iRhythm Technologies Inc (iRhythm) is a digital health care solutions company. It offers non-invasive long-term cardiac rhythm monitors. The company develops the Zio family of products and services to address the clinical needs of patients suffering from arrhythmias. Its product offerings in …
  • MedMira Inc (MIR)-医療機器分野:企業M&A・提携分析
    Summary MedMira Inc (MedMira) is a medical device company that offers rapid diagnostics and technology solutions. The company offers products in areas of HIV, H. pylori, syphilis, multiplex, miriad rvf toolkit, and tissue and eye banks. It offers testing products for HIV, H. Pylori and syphilis, bes …
  • Asahi Group Holdings Ltd:企業のM&A・事業提携・投資動向
    Asahi Group Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Asahi Group Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Provimi Holding BV:企業の戦略・SWOT・財務分析
    Provimi Holding BV - Strategy, SWOT and Corporate Finance Report Summary Provimi Holding BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bharti Airtel Limited:企業の戦略・SWOT・財務情報
    Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report Summary Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alnylam Pharmaceuticals Inc (ALNY):企業の財務・戦略的SWOT分析
    Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Delek Group Ltd:企業のM&A・事業提携・投資動向
    Delek Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Delek Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • University of Pittsburgh Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Pittsburgh Medical Center (UPMC) is a health care provider organization. It is a non-profit health care firm comprising a wide network of hospitals, clinics, and long-term care, rehabilitation and retirement facilities. The company offers several services such as commercial, me …
  • BioStar Pharmaceuticals Inc (BSPM):企業の財務・戦略的SWOT分析
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Genzyme Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosi …
  • MaaT Pharma:製薬・医療:M&Aディール及び事業提携情報
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company focuses on developing MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovative device for stool collection and storage. It also …
  • TIM SpA (TIT):企業の財務・戦略的SWOT分析
    TIM SpA (TIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆